Ketamine-Assisted Psychotherapy
5,000+ treatments across two clinics since 2018. We combine IV ketamine with structured psychotherapy for treatment-resistant depression, PTSD, addiction, and eating disorders. This talk covers what actually happens in a treatment room, how we select and prepare patients, what the clinical outcomes look like after seven years of practice, and why the combination of pharmacology and psychotherapy matters more than either alone.
Ketamine occupies a unique position in psychedelic medicine. It is the only psychedelic-class substance legally available for clinical use in most countries, yet it remains poorly understood by many practitioners and frequently reduced to its reputation as an anaesthetic or a party drug. I have administered over 5,000 ketamine treatments since 2016 and published research on its mechanisms, clinical applications, and phenomenology.
This talk explores ketamine's pharmacology as an NMDA antagonist, its relationship to classical psychedelics, and the growing evidence base for ketamine-assisted psychotherapy across depression, PTSD, addiction, and eating disorders. I address the dissociative experience directly: what patients report, what predicts therapeutic benefit, and how the subjective experience relates to clinical outcome.
Audiences range from psychiatrists encountering ketamine for the first time to experienced practitioners refining their protocols. I draw on both published research and clinical observation from Scandinavia's largest KAP practice.
Talks
Ketamine: The Psychedelic Elephant in the Room
History, phenomenology, mechanisms and evolution of ketamine use in treatment of mental health disorders.
Ketamine for the treatment of substance use disorders
Ketamine in a Therapeutic Setting as Treatment for Alcohol/Substance Use Disorder
Panel on using ketamine to treat substance use disorder.
Alle mann til pumpene! Dosering, titrering og vedlikehold
Practical session on ketamine dosing, titration and maintenance for physicians and leaders. Co-presented with Rupert McShane (University of Oxford).